{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:35:11Z","timestamp":1725496511937},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68610","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T09:33:15Z","timestamp":1725442395000},"source":"Crossref","is-referenced-by-count":0,"title":["Helmut Gadner: A Charismatic Leader, Visionary, and Pioneer in Pediatric Oncology"],"prefix":"10.7759","author":[{"given":"Milen","family":"Minkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Kager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Helmut Gadner. (2015). Accessed. 28.07.2024: https:\/\/de.wikipedia.org\/wiki\/Helmut_Gadner."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111331","article-title":"A randomized trial of treatment for multisystem Langerhans' cell histiocytosis","volume":"138","author":"Gadner H","year":"2001","unstructured":"Gadner H, Grois N, Arico M, et al.. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr. 2001, 138:728-34. 10.1067\/mpd.2001.111331","journal-title":"J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-106211","article-title":"Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification","volume":"111","author":"Gadner H","year":"2008","unstructured":"Gadner H, Grois N, P\u00f6tschger U, et al.. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood. 2008, 111:2556-62. 10.1182\/blood-2007-08-106211","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner H","year":"2013","unstructured":"Gadner H, Minkov M, Grois N, et al.. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013, 121:5006-14. 10.1182\/blood-2012-09-455774","journal-title":"Blood"},{"key":"ref5","unstructured":"35th anniversary report. 35 years St. Anna Children's Cancer Research Institute. (2023). Accessed: 16.08.2024: https:\/\/ccri.at\/35-years-anniversary-report-st-anna-ccri\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1337953","article-title":"The life and work of Professor Riehm from a participant's perspective","volume":"225 Suppl 1","author":"Gadner H","year":"2013","unstructured":"Gadner H. The life and work of Professor Riehm from a participant's perspective. Klin Padiatr. 2013, 225 Suppl 1:S3-4. 10.1055\/s-0033-1337953","journal-title":"Klin Padiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-74643-7_81","article-title":"Results and significance of six randomized trials in four consecutive ALL-BFM studies","volume":"33","author":"Riehm H","year":"1990","unstructured":"Riehm H, Gadner H, Henze G, et al.. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus. 1990, 33:439-50. 10.1007\/978-3-642-74643-7_81","journal-title":"Haematol Blood Transfus"},{"key":"ref8","article-title":"The West-Berlin therapy study of acute lymphoblastic leukemia in childhood-report after 6 years (author\u2019s transl) (Article in German)","volume":"189","author":"Riehm H","year":"1977","unstructured":"Riehm H, Gadner H, Welte K. The West-Berlin therapy study of acute lymphoblastic leukemia in childhood-report after 6 years (author\u2019s transl) (Article in German). Klin Padiatr. 1977, 189:89-102.","journal-title":"Klin Padiatr"},{"key":"ref9","unstructured":"Helmut Gadner. (2000). Accessed. 16.08.2024: https:\/\/www.oeaw.ac.at\/m\/gadner-helmut."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1026785","article-title":"Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study (Article in German)","volume":"199","author":"Gadner H","year":"1987","unstructured":"Gadner H, Heitger A, Ritter J, et al.. Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study (Article in German). Klin Padiatr. 1987, 199:173-82. 10.1055\/s-2008-1026785","journal-title":"Klin Padiatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950230203","article-title":"Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group","volume":"23","author":"Gadner H","year":"1994","unstructured":"Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol. 1994, 23:72-80. 10.1002\/mpo.2950230203","journal-title":"Med Pediatr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240407","article-title":"Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study","volume":"24","author":"Grois N","year":"1995","unstructured":"Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol. 1995, 24:248-56. 10.1002\/mpo.2950240407","journal-title":"Med Pediatr Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9667","article-title":"Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group","volume":"212","author":"Minkov M","year":"2000","unstructured":"Minkov M, Grois N, Heitger A, P\u00f6tschger U, Westermeier T, Gadner H. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klin Padiatr. 2000, 212:139-44. 10.1055\/s-2000-9667","journal-title":"Klin Padiatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950170527","article-title":"Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society","volume":"17","author":"Broadbent V","year":"1989","unstructured":"Broadbent V, Gadner H, Komp DM, Ladisch S. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol. 1989, 17:492-5. 10.1002\/mpo.2950170527","journal-title":"Med Pediatr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950230207","article-title":"LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society","volume":"23","author":"Ladisch S","year":"1994","unstructured":"Ladisch S, Gadner H, Aric\u00f2 M, et al.. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Med Pediatr Oncol. 1994, 23:107-10. 10.1002\/mpo.2950230207","journal-title":"Med Pediatr Oncol"},{"key":"ref16","article-title":"Histiocytosis syndromes in children. Writing Group of the Histiocyte Society","volume":"1","year":"1987","unstructured":"Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet. 1987, 1.208-9.","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1429405","article-title":"An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy","volume":"19","author":"Minkov M","year":"2018","unstructured":"Minkov M. An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy. Expert Opin Pharmacother. 2018, 19:233-42. 10.1080\/14656566.2018.1429405","journal-title":"Expert Opin Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005442","article-title":"Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis","volume":"6","author":"Eder SK","year":"2022","unstructured":"Eder SK, Schwentner R, Ben Soussia P, et al.. Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis. Blood Adv. 2022, 6:970-5. 10.1182\/bloodadvances.2021005442","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0138","article-title":"Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis","volume":"9","author":"Halbritter F","year":"2019","unstructured":"Halbritter F, Farlik M, Schwentner R, et al.. Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis. Cancer Discov. 2019, 9:1406-21. 10.1158\/2159-8290.CD-19-0138","journal-title":"Cancer Discov"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-410241","article-title":"Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells","volume":"120","author":"Hutter C","year":"2012","unstructured":"Hutter C, Kauer M, Simonitsch-Klupp I, et al.. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood. 2012, 120:5199-208. 10.1182\/blood-2012-02-410241","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289306-helmut-gadner-a-charismatic-leader-visionary-and-pioneer-in-pediatric-oncology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T09:33:20Z","timestamp":1725442400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289306-helmut-gadner-a-charismatic-leader-visionary-and-pioneer-in-pediatric-oncology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.68610","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}